Badgwell, D., Lu, Z., Cole, L., Fritsche, H., Atkinson, E. N., Somers, E., . . . Bast, R. C. (2007). Urinary Mesothelin Provides Greater Sensitivity for Early Stage Ovarian Cancer than Serum Mesothelin, Urinary hCG Free Beta Subunit and Urinary hCG Beta Core Fragment.
Styl ChicagoBadgwell, Donna, et al. Urinary Mesothelin Provides Greater Sensitivity for Early Stage Ovarian Cancer Than Serum Mesothelin, Urinary HCG Free Beta Subunit and Urinary HCG Beta Core Fragment. 2007.
Citace podle MLABadgwell, Donna, et al. Urinary Mesothelin Provides Greater Sensitivity for Early Stage Ovarian Cancer Than Serum Mesothelin, Urinary HCG Free Beta Subunit and Urinary HCG Beta Core Fragment. 2007.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..